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Photodynamic therapy (PDT) and photodynamic diagnostics (PDD) of cancer are based on the use of non-toxic dyes (photosensi-
tisers) in combination with harmless visible light. This paper reports physicochemical properties, cell uptake, localisation as well as pho-
todynamic efficiency of two novel lipophilic porphyrin derivatives, suitable for use as PDT sensitisers. Both compounds are characterised
by high quantum yield of singlet oxygen generation which was measured by time-resolved phosphorescence. Photodynamic in vitro stud-
ies were conducted on three cancer cell lines. Results of cell survival tests showed negligible dark cytotoxicity but high phototoxicity. The
results also indicate that cell death is dependent on energy dose and time following light exposure. Using confocal laser scanning micros-
copy both compounds were found to localise in the cytoplasm around the nucleus of the tumour cells. The mode of cell death was eval-
uated based on the morphological changes after differential staining.
In summary, good photostability, high quantum yield of singlet oxygen and biological effectiveness indicate that the examined lipo-
philic porphyrin derivatives offer quite interesting prospects of photodynamic therapy application.
 2006 Elsevier B.V. All rights reserved.
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Photodynamic therapy (PDT) is a relatively novel and
promising anticancer therapy based on combined use of a
photosensitising agent and visible or near-infrared light
[1]. It can be very effective in destroying tumour cells and1011-1344/$ - see front matter  2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.jphotobiol.2005.12.011
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E-mail address: kramer_gabriela@yahoo.co.uk (G. Kramer-Marek).side effects in healthy tissues are relatively low [2,3]. Gener-
ally, PDT is based on photoactivation of a sensitiser taken
up by targeted (i.e., cancer) cells. Two types of reaction can
occur after photoactivation of the photosensitiser. The first
involves generation of free radicals like superoxide anion,
O2 (type I); the second produces singlet molecular oxygen
1O2 (
1Dg) (type II), possibly the main species responsible for
oxidising neighbouring molecules [4,5]. Highly reactive
oxygen species formed within cell membrane, cytoplasm
or organelles lead to peroxidative reactions causing dam-
age to DNA and other molecules and finally resulting in
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cells although precise mechanisms underlying this process
are not completely characterised [7,8]. A second mode of
cell death observed in PDT is necrosis [9].
Porphyrins and porphyrin-related macrocycles are
among the sensitisers most frequently used in PDT. Once
inside the cell, they bind to apolar endocellular matrices
such as lysosomes, mitochondria or/and plasma mem-
branes. The site of porphyrin action depends on its polarity
and, to some extent, is cell-line dependent [7,10].
Among the first-generation photosensitisers the most
popular is Photofrin II, widely used in clinical practice
[11,12]. However, its applications remain limited because
Photofrin II is a complex mixture with low extinction
coefficient in the red spectral region. This implies admin-
istration of relatively large amounts of this drug in order
to obtain satisfactory phototherapeutic response. In con-
sequence, due to high drug accumulation, patients have
to stay several days out of sunlight to avoid sunburn
reactions. These drawbacks have stimulated the search
for photosensitising agents with improved optical and
pharmacokinetic characteristics.
Two synthetic porphyrin derivatives: 5-(4-hydroxyphe-
nyl)-10,15,20-tritolylporphyrin and 5-(4-hexadecyloxyphe-
nyl)-10,15,20-tri-pyridylporphyrin were synthesised in our
laboratory. The structures of these compounds are shown
in Fig. 1 and for convenience they will be referred to as
C16-TTP and TPYR-PP, respectively. They have been
shown to possess suitable chemical purity, relatively high
absorption coefficient in the phototherapeutic windows
(600–800 nm), as well as high quantum yield of singlet oxy-
gen generation that favour their use as potential photody-
namic agents.
In this paper, we describe the synthesis and photochem-
ical properties of these porphyrins. Particular attention is
given to the time-resolved singlet oxygen phosphorescence
as a measure of C16-TTP and TPYR-PP singlet oxygen
quantum yield (UD). The results of cytotoxicity and photo-
toxicity studies as well as cellular localisation and the effect
of radiation dose for cell death induction in different
tumour cell lines are also presented.H
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Fig. 1. The structure of 5-(4-hexadecyloxyphenyl)-10,15,20-tri-pyridylporphyr
TTP).2. Materials and methods
2.1. Materials
5-(4-Hydroxyphenyl)-10,15,20-tritolylporphyrin (C16-
TTP) was synthesised as described elsewhere [13]. Briefly,
50 mg of hydroxyphenylporphyrin, 50 mg of cetyl bromide,
2 g of anhydrous potassium carbonate and 20 ml of
dimethyl formamide (DMF) were placed in a flask and stir-
red at room temperature (RT) for 5 h. The reaction pro-
gress was checked using TLC (silica gel/chloroform). One
hundred millilitre of water was added to the reaction and
the resulting mixture was extracted three times using ethyl
acetate (3 · 20 ml). The extracts were washed five times
with water, dried over anhydrous MgSO4 and evaporated.
The raw product was washed with 30 ml of methanol. Pre-
cipitated porphyrin was separated and air-dried. The prod-
uct was purified twice on a silica gel column using hexane
(to remove excess cetyl bromide) and eluted with
chloroform.
Yield: 75%. 1H NMR (500 MHz, CDCl3): d = 8.83 (m,
8H, b-H), 8.06, 7.51 (dd, 12H, ArH), 8.07, 7.21 (dd, 4H,
ArH), 4.21 (t, 2H, O–CH2), 2.67 (s, 9H, ArCH3), 1.94 (q,
2H), 1.62 (q, 2H), 1.36–1.10 (m, 22H), 0.85 (t, 3H),
2.79 (s, 2H, NH); ESI-MS: m/z = 897 (100%, (M +
H)+); C63H68N4O: Calcd. C, 84.33; H, 7.64; N, 6.24.
Found: C, 83.95; H, 7.74; N, 6.58%.
5-(4-Hexadecyloxyphenyl)-10,15,20-tri-pyridylporphyrin
(TPYR-PP) was synthesised using the procedures partly
described elsewhere [14]. Briefly, 2.12 g of p-hexadecyloxy-
benzaldehyde, 1.82 g of 4-pyridylcarboxyaldehyde and
1.25 g of pyrrole were heated for 30 min in boiling propi-
onic acid. After 24 h, an excess of acid was distilled out
and the mixture was extracted with ethyl acetate. Then,
extract was dried with anhydrous MgSO4. The end-prod-
ucts were separated by column chromatography and the
compound of interest eluted.
Yield: 15%. 1H NMR (500 MHz, CDCl3): d = 8.14, 9.02
(dd, 12Hpyr, J = 5,4 Hz), 8,78, 8.94 (dd, 4H, b-H), 8.82 (bs,
4H, b-H), 8.07, 7.27 (dd, 4H, ArH, J = 8.4 Hz), 4.23 (t,
2H), 1.96 (q, 2H), 1.45 (q, 2H), 1.40-1.20 (m, 22H), 0.76CH3
R
O
C16-TTP
in (TPYR-PP) and 5-(4-hydroxyphenyl)-10,15,20-tritolylporphyrin (C16-
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(M + H)+); C57H59N7O1: Calcd. C, 76.56; H, 7.10; N,
10.96. Found: C, 76.79; H, 6.76; N, 10.81%.
Photofrin II was purchased from Axcan Pharma Com-
pany. For in vitro confocal microscopy studies it was dis-
solved in distilled water at a maximum concentration of
2 mg/ml and diluted using DMEMmedium without phenol
red. A pure sample of 5,10,15,20-tetraphenylporphyrin
(TPP) was available from previous studies [15].
2.2. Photophysical studies
In the photophysical characterisation of the sensitisers
toluene was used as a solvent. The results obtained should
be indicative of sensitiser behaviour in cellular environ-
ment, although absolute values should be looked with cau-
tion as deviations may arise due to specific interactions.
The ground-state absorption and luminescence spectra
were recorded at room temperature with a Shimadzu
UV-2100 spectrophotometer and SPEX Fluorolog 111
spectrophotometer, respectively. Transient triplet–triplet
absorption was measured with an Applied Photophysics
LKS.60 flash kinetic spectrometer; excitation was achieved
with the third harmonic of a Nd/YAG laser (Spectra-Phys-
ics Quanta Ray GCR 130).
Singlet oxygen phosphorescence was detected at room
temperature using an adaptation of the LKS.60 spectrom-
eter. The singlet oxygen emission was detected using a
Hamamatsu R5509-42 photomultiplier, cooled to 193 K
in a liquid nitrogen chamber (Products for Research, model
PC176TSCE005), following Nd/YAG laser excitation of
aerated toluene solutions containing the sensitiser at a con-
centration necessary to produce absorbance in the 0.15–
0.30 range at the excitation wavelength (355 nm). Under
these conditions there was no indications of porphyrins’
aggregation.
The modification of the spectrometer involved the inter-
position of a Melles Griot dielectric mirror (08MLQ005/
345), that reflects more than 99.5% of the incident light
in the 610–860 nm range and a Scotch RG665 filter. A
600 line diffraction grating was mounted in place of a stan-
dard one. This equipment allows spectral identification of
the singlet oxygen phosphorescence and measurement of
singlet oxygen lifetime in the nanosecond and microsecond
ranges [16]. The filters employed are essential in eliminating
from the infrared signal all first-harmonic contributions of
the sensitiser emission in the 500–800 nm range.
2.3. In vitro studies
2.3.1. Cell cultures
Human malignant melanoma (Me45) cell line (derived
from a lymph node metastasis of skin melanoma in a 35-
year-old male) was established in 1997 at the Radiobiology
Department of the Centre of Oncology in Gliwice. Identity
of melanoma cells was confirmed by immunocytochemical
reaction with DAKO monoclonal antibodies HMB 50,S-100 and Melan A (Widel, unpublished). Human colon
adenocarcinoma (Hct116) was obtained from American
Type Culture Collection. Murine melanoma (B16(F10))
was obtained from Wistar Institute, Philadelphia, PA,
USA. Cells were grown as monolayer cultures in 75 cm2
flasks (Nunc)/37 C, humidified atmosphere, 5% CO2/
using the following media: DMEM (Me45), McCoy
(Hct116) and RPMI (B16(F10)) from Sigma–Aldrich, sup-
plemented with 10% foetal bovine serum (Gibco-BRL) and
100 lg/ml of gentamycin (Polfa).
2.3.2. Liposome preparation
Liposomes used in this study contained a cationic com-
ponent, cetylated polyethylenimine (CT-PEI), obtained by
partially substituting amine groups of low-molecular-
weight polyetylenimine with cetyl residues. Synthesis of
CT-PEI was performed according to Yamazaki et al. [17].
In brief, Epomin (low-molecular-weight polyethylenimine
600, Nippon Shokubai Ltd., Japan) was refluxed with cetyl
bromide (Sigma–Aldrich) in the presence of triethylamine
for 12 h at 63 C. The product was dialysed against 40%
ethanol, then against water, and finally lyophilised.
The final product was 1H NMR-analysed using Unity
Inova-300 spectrometer operating at 300 MHz frequency
(Institute of Organic Chemistry and Technology, Silesian
Technical University in Gliwice, Poland) with deuterated
chloroform as solvent and tetramethylsilane as reference.
The liposomes were prepared by mixing aliquots of chloro-
form solutions (10 mg/ml) of CT-PEI, cholesterol, and
TPYR-PP or C16-TTP at appropriate molar ratios and
spin-evaporating the resulting preparations. Dry lipid films
were rehydrated at 4 C for 1 h and sonicated with tip
probe until emulsions became clear (two or three 3-min
cycles, medium power, Branson sonifier).
2.3.3. In vitro transfection studies
Transfection studies with cationic liposome-plasmid
DNA complexes (lipoplexes) at various stoichiometric
ratios were performed in order to check cellular internalisa-
tion of constructs containing the synthesised compounds.
Transfection calibration was achieved by employing com-
plexes containing plasmid DNA (Promega) with luciferase
reporter gene insert. The resulting luminescence of
expressed luciferase protein was quantified using a Bert-
hold luminometer. One day prior to transfection, cells were
seeded onto 24-well plates at 5 · 104 cells/well. When cul-
tures reached about 80% confluence, appropriate dilutions
of liposome emulsions were prepared in 100 ll final volume
using polystyrene tubes (Sarstedt). Separately, appropriate
dilutions of 1 lg plasmid DNA were prepared in polysty-
rene tubes in 100 ll final volume. DNA solutions were
added drop wise to liposomal emulsions with gently mix-
ing. Following 15-min incubation at room temperature
2.8 ml of suitable medium (Opti-MEM, Gibco-BRL) was
added. After removal of growth medium the transfection
mixtures were transferred to the culture wells. Cells were
incubated for 4 h at 37 C and 5% CO2. At the end of
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with regular growth medium. After 24 h cells in each well
were lysed using a kit-included lysis buffer (Promega).
The lysates were centrifuged for 30 min at 15,000 rpm
and 4 C. The supernatants (300 ll) were transferred into
fresh test tubes. Luciferase activity was determined using
a Berthold luminometer, in supernatant aliquots (20 ll or
less), after addition of 100 ll of enzyme substrate. Lucifer-
ase activity was expressed as relative luminescence units
(RLU) per milligram of protein in cell culture homoge-
nates. Lysate protein content was measured by Bradford
method using a BioRad kit and BSA calibration.
2.3.4. Photostability studies of the compounds
Photostability of the photosensitisers was determined by
irradiating 1 lM solutions of the phorphyrins incorporated
into liposomes. Two different light doses were used (7.5 and
15 J/cm2). During such irradiation the solutions were mag-
netically stirred and kept at room temperature. After
appropriate time intervals concentration of the porphyrins
was determined using absorption spectrophotometer. The
photostability was calculated as the ratio of residual absor-
bance after determined irradiation time and the absorbance
value measured before irradiation.
2.3.5. Cytotoxicity and phototoxicity
For irradiation experiments, exponentially growing cells
were harvested by trypsinisation of subconfluent cultures.
Cells were then seeded at 8 · 104 cells/35 mm dish (Nunc).
After 18 h incubation, the growth medium was exchanged
for medium containing preselected (i.e., the best in terms
of liposome stability and transfection efficiency) formula-
tion of lipoplexes (6:1 lipid to DNA, w/w, final concentra-
tion of porphyrins 1 lM) and cells were incubated 4 h in
the dark. A representative experiment calibrating liposome
to DNA ratio is shown in Fig. 2, for details see Section
2.3.3. Prior to light exposure, cells were washed three times0,00E+00
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Fig. 2. Luciferase expression in Hct116 cells following transfection with p
polyethylenimine CT-PEI, cholesterol (1:1 mol/mol) and C16-TTP.with phenol red-free medium (DMEM). The dishes were
then exposed to different light doses (2.5–15 J/cm2). First
control group (no photosensitiser) was also treated with
red light. The second control group, containing photosen-
sitiser, was not exposed to light (dark control) and served
for cytotoxicity assay. The light source was a halogen lamp
(250 W, 24 V) with heat isolation filter and 610 nm long-
pass filter. The total power output (measured at the culture
solution surface) was 8.5 mW/cm2, as indicated by Radi-
ometer Laser Mate-Q, Coherent. Immediately after irradi-
ation the medium was replaced with fresh aliquot
supplemented with 10% FBS and cells were further incu-
bated for 12 or 24 h under standard culture conditions.
2.3.6. Cell viability
Cell viability was monitored by MTS-tetrazolium
reduction assay (Promega) which relies on the ability of
viable cells to reduce the colourless blue-tetrazolium salt
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazol) to colour formazan. MTS,
which measures mitochondrial dehydrogenase activity,
was added to cell cultures 12 and 24 h after treatment
with photosensitisers and/or light, according to the man-
ufacturer’s instructions. Absorbance measurements at
490 nm were performed using Elx800 universal plate
reader (Biotek Instruments, Inc.). A standard solution
containing 100 ll of DMEM without phenol red and
20 ll of MTS solution was used to determine ‘‘blank’’
absorbance. Survival of PDT-treated cells was normalised
against control cells that were only incubated (not irradi-
ated). The results are reported as mean ± SD of three sep-
arate experiments.
2.3.7. Clonogenic survival assay
Clonogenic potential of cells subjected to PDT treat-
ment following transfer of C16-TTP and TPYR-PP con-
taining constructs was assessed as described by:1 5:1 6:1 7:1 8:1
es/DNA [w/w]
lasmid DNA (pVR1255). Complexed to liposomes containing cetylated
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mm dishes (Nunc) were subjected to PDT, as described in
Section 2.3.4. After irradiation with different light doses,
cells were trypsinised and seeded, at different densities, in
60-mm dishes. Cells were then incubated for 9 days at
37 C in humidified atmosphere. The colonies were then
fixed and stained with 0.5% methylene blue in 50% ethanol
and the number of colonies containing more than 50 cells
was counted. The surviving fraction was calculated as the
relative plating efficiency of PDT-treated vs. non-PDT-
treated cells (no drug, no light).
2.3.8. Sensitiser localisation (confocal microscopy)
To visualise the sensitisers accumulation within the cells,
3 · 104 Me45 cells in 800 ll growth medium were plated
into 4-well chambered coverglass (Nunc) and incubated
for 18 h. Then, cells were transfected with liposome com-
plexes containing C16-TTP or TPYR-PP (final concentra-
tion 1 lM), as described in Section 2.3.3. Following 4 h
incubation cells were washed three times in phosphate-buf-
fered saline (PBS, pH 7.2) and covered with 800 ll of fresh
growth medium. Thirty minutes before analysis cells were
labelled with 5 lM CellTracker Green CMFDA (5-chlo-
romethylfluorescein diacetate; Molecular Probes). This
reagent passes freely through cell membrane but, once
inside the cell, its chloromethyl group reacts with thiols
and the reagent is transformed into membrane-impermeant
thioether adduct, fluorescing after esterases-mediated
cleavage of acetate moiety. It allows localising targeted
cells and assessing their viability. After 4 and 12 h incuba-
tion intracellular localisation of porphyrin derivatives was
monitored using LSM 510 confocal laser scanning micro-
scope (Carl Zeiss GmbH). CellTracker Green CMFDA
and porphyrins were excited using argon–ion laser
488 nm line and helium–neon laser 543 nm line, respec-
tively. The fluorescence was filtered with 505 nm band-pass
and 560 nm long-pass emission filters. To reduce inter-
channel cross-talk a multitracking technique was used.
Image acquisition was performed using 40 · 1.30 NA oil
immersion objective lens (resolution: 512 · 512 or
1024 · 1024 pixels; optical slice thickness: 1 lm). Images
were stored in TIF format and analysed using KS400 soft-
ware (Carl Zeiss GmbH). Five images were taken for each
kind of lipoplex-associated porphyrins and controls cell
cultures (without lipoplexes added). Every image featured
5–7 cells. Using green image channel the mask for defini-
tion of ROI was generated. In such defined regions mean
densitometric signal value was calculated after background
fluorescence subtraction.
To determine exact intracellular localisation of drugs 3D
reconstructions of specified cells were generated. Our
source image stacks consisted of 55 (two-channel, 1024 ·
1024 pixels) images taken every 0.4 lm. Final resolution
of this reconstruction was 0.16 lm/pixel horizontally and
0.4 lm/pixel vertically. Acquisition time was 1.17 s per
image (65 s for entire stack). Using these stacks horizontal
and vertical projections were generated.2.3.9. Determination of apoptotic cells
To study the mode of cell death following PDT we used
differential staining of apoptotic and necrotic cells with
acridine orange/ethidium bromide (AO/EB) [19,20].
Tumour cells (Me45) growing on 35 mm culture dishes
were transfected with porphyrin-carrying liposomes for
4 h as described in Section 2.3.3 and irradiated with two
different light energy doses: 7.5 and 15 J/cm2. Next, cells
were washed with fresh medium and incubated 0–24 h.
At times 0, 3, 6, 12 and 24 h cells were trypsinised, pelleted,
suspended in 25 ll of phosphate buffered saline (PBS) and
1 ll of AO/EB (1:1, 10 lM) solution was added. A drop of
cell suspension was placed on microscope slide and ana-
lysed at 400· magnification under fluorescence microscope
(AXIOPHOT, Zeiss-Opton) equipped with band-pass filter
for 400–500 nm wavelength. One thousand cells were
scored and percentage of live, apoptotic and necrotic cells
was calculated. Live cells contain green fluorescent regular
nuclei with orange granules in the cytoplasm; apoptotic
cells present nuclei with intense green fluorescence from
condensed chromatin (early apoptosis) and bright orange
fluorescence from highly condensed and/or fragmented
chromatin (late apoptosis); necrotic cells possess regular
orange-stained nuclei and often disrupted cell membrane
which is clearly seen using phase-contrast objective [20].
3. Results
3.1. Photophysics and photochemistry
C16-TTP and TPYR-PP show typical spectroscopic fea-
tures of free-base porphyrins (intense Soret band) in the
violet range of the visible region (e > 105 M1 cm1) and
four wide Q-bands localised in the 500–650 nm region
(e 6 104 M1 cm1); the data are summarised in Table 1.
The band absorption coefficient was calculated from Lam-
bert–Beer law using solutions in the 104–106 M concen-
tration range. The relative intensity of the Q-bands
indicates an etio-type spectrum (eIV > eIII > eII > eI), [21].
Good linear plots (rP 0.999) that pass through the origin
were obtained, indicating that there is no compound aggre-
gation under these conditions. However, this does not
exclude the possibility of aggregation inside cells in vitro,
which is often the case for this kind of compounds.
The steady-state fluorescence emission spectra of these
porphyrins present two maxima which have been assigned
to Q(0–0) and Q(0–1) transitions, see Table 1. A very small
(5 nm) Stokes shift between last band of absorption
Qx(0–0) and first emission band Q(0–0), characteristic for
monomeric porphyrins, was also observed indicating that
the spectroscopic energy is nearly identical to the relaxa-
tion energy of the singlet state. The fluorescence quantum
yield (UF) was calculated by steady-state comparative
method using TPP as reference. The spectroscopic sin-
glet-state energies (ES) were obtained from the intersection
of the normalised absorption and fluorescence spectra. No
phosphorescence was observed at 77 K in toluene glasses.
Table 1
Absorption and luminescence data for free bases in deaerated toluene solution
Compound Absorption kmax/nm (e/M
1 cm1) Fluorescence
kmax/nm
UF ES/kJ mol
1
Q(0–0) Q(0–1)
TPP 649.8 592 548.8 514.6 419.6 652 719 0.10 ± 0.1 183.5
(9.0 · 103) (1.0 · 104) (1.6 · 104) (2.7 · 105) (1.0 · 104)
C16-TTP 650 593 552 526 420 655 718 0.11 ± 0.1 182.9
(1.8 · 103) (2.0 · 104) (4.0 · 104) (7.2 · 104) (1.9 · 105)
TPYR-PP 647 591 549 515 420 652 714 0.11 ± 0.1 183.5
(6.1 · 103) (2.5 · 104) (3.4 · 104) (8.7 · 104) (1.8 · 105)
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related porphyrins [15,22,23].
Triplet–triplet absorption spectra of both porphyrins
presented typical intense absorption band at 460 nm
and the ground state bleaching bands. Triplet state life-
times in presence (air-equilibrated samples) and absence
of oxygen were obtained. Triplet quantum yields (UT) were
calculated using a published procedure [24] (see Table 2).
3.2. Quantum yield of singlet oxygen generation
Singlet oxygen quantum yields (UD) were obtained by
comparing the intensity of singlet oxygen emission at
1270 nm in an air-equilibrated sample containing a given
sensitiser against the intensity obtained from an optically
matched sample containing a reference sensitiser. The laser
power employed was varied until reaching the lowest emis-
sion signal limit (Fig. 3). We employed 1H-phenalen-1-one
as a reference. The literature value for the singlet oxygen
quantum yield in toluene, obtained for this sensitiser is
0.95 [25].
The studied molecules generate a species emitting at
1270 nm with the lifetime between 32 and 35 ls (Table 2).
These values are in good agreement with lifetime of singlet
oxygen phosphorescence in the solvent used, confirming
the origin of the emission measured [26]. Also, the shape
of emission spectra taken between 1200 and 1350 nm corre-
sponds to that emission, with a maximum at 1270 nm [27].
The oxygen quantum yield values obtained for TPP and
Photofrin II (0.62 and 0.32, respectively) are in full agree-
ment with those found in the literature [28,29], which vali-
dates the method used. The value of 0.32 obtained for the
complex mixture Photofrin II in toluene is within the range
of the values obtained for pure hematoporphyrins in thisTable 2
Triplet state characterisation, singlet oxygen lifetimes and quantum yields
Compound Triplet lifetime (N2)/ls Triplet lifetime (air)/ns
1H-phenalen-1-one – –
TPP >10a 196a
Photofrin II – –
C16-TTP 64 338
TPYR-PP 43 315
a Ref. [15].
b Ref. [30].solvent [30]. C16-TTP has a singlet oxygen quantum yield
(0.66) comparable to that of TPP, twice the value for
Photofrin II under the same measuring conditions.
TPYR-PP yield of singlet oxygen generation reaches the
value of 0.82 which is quite enhanced, compared to those
for Photofrin II or even C16-TPP and TPP (Table 2).
The value obtained for TPYR-PP can be compared with
the value obtained by Postigo et al. [31] for tetra-pyr-
idylporphyrin in the same solvent (0.85).
3.3. Photostability of compounds
In all cases, exposure of liposome-incorporated porphy-
rins to light doses used in phototoxicity studies caused a
negligible decrease in the intensity of the visible absorption
bands. This process, generally defined as photobleaching, is
usually related to irreversible destruction of the tetrapyrr-
olic macrocycle. The data in Table 3 evidently suggest that
TPYR-PP and C16-TTP have shown high photostability
under the conditions used for PDT tests.
3.4. PDT effects on the cell growth and survival
The purpose of this group of experiments was to deter-
mine the degree of dark toxicity and phototoxicity of C16-
TTP and TPYR-PP for various transfected cell lines
following exposure to different doses of light. The use of
cationic liposomes as photosensitiser vehicles transporting
hydrophobic constitutes an advantage for their use in
PDT, since liposomes optimise the release of lipophilic sen-
sitisers to low density lipoproteins LDL. The percentage of
cell survival was measured by normalising the results of
MTS assay with cells that were neither exposed to porphy-
rins nor to light.UT
1O2 emission lifetime/ls
1O2 quantum yield
– 32.0 ± 0.8 0.95
0.73a/0.67b 32.9 ± 1.2 0.62
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Table 3
Photostability percentage of the photosensitisers after irradiation with
different light doses
Compound Energy dose/J cm2
0 7.5 15
C16-TTP 100 99 98
TPYR-PP 100 98 94
G. Kramer-Marek et al. / Journal of Photochemistry and Photobiology B: Biology 84 (2006) 1–14 7Figs. 4 and 5 show the characteristics of C16-TTP and
TPYR-PP phototoxicity after exposure to five doses of
light irradiation, respectively. Cell viability was measured
12 h (A) and 24 h (B) post-irradiation in three different cell
lines. When the cells were exposed to light in the absence of
the compounds no toxicity was recorded (data not pre-
sented). Only negligible proliferative change was observed
when the treatment with drug was conducted in the absence
of light (0 energy dose in Figs. 4 and 5). This proves that
neither light nor photosensitiser are toxic separately. When
incubating cells with studied agents and irradiating them
with various energy doses cells demonstrated inhibited pro-
liferation compared to control. As expected, cell survival
was dependent on the dose of energy used and was signif-
icantly decreased when the dose was raised. The survival
effect was also proportional to the time period elapsed fromconclusion of light exposure. Comparing the effectiveness
of the studied compounds TPYR-PP derivative turned
out to be more efficient than C16-TTP, demonstrating
results after 24 h from light irradiation.
Human melanoma (Me45) appears to be the most resis-
tant cell line. In contrast, human colon adenocarcinoma
(Hct116) shows greatest sensitivity to irradiation after
24 h post-light exposure. We have also calculated the
LD50, i.e., the light dose, required for killing 50% of the
cells at a given drug concentration (Figs. 4 and 5). For
Hct116 line cells treated with C16-TTP after 12 and 24 h
from the conclusion of light exposure the required energy
dose to observe this effect was 5 and 3 J/cm2, respectively.
LD50 figured out for Me45 cell line after 12 h was
12.5 J/cm2 and after 24 h it was 7.5 J/cm2. The most resis-
tant to C16-TTP-mediated PDT treatment was B16(F10)
melanoma which required 15 J/cm2 after 12 h and nearly
10 J/cm2 after 24 h, respectively. In case of using TPYR-
PP the energy dose leading to 50% B16(F10) cell death
was 7.5 J/cm2 after 12 h. For the two remaining cell lines
the dose was nearly twice higher. After 24 h the LD50 dose
was similar for all cell lines studied, ca. 6-7.5 J/cm2. At a
light dose of 15 J/cm2 after 24 h from using TPYR-PP
the survival of Hct116 cells was less than 10%. These results
indicate that both compounds show PDT effect.
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Fig. 4. Cytotoxicity of C16-TTP determined by MTS colorimetric assay at
12 h (A) and 24 h (B) after PDT treatment. Three cell lines were exposed
to different light doses (2.5–15 J/cm2). Data are expressed as mean ± SD
from at least three independent experiments.
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Fig. 5. Cytotoxicity of TPYR-PP determined by MTS colorimetric assay
at 12 h (A) and 24 h (B) after PDT treatment. Three cell lines were exposed
to different light doses (2.5–15 J/cm2). Data are expressed as mean ± SD
from at least three independent experiments.
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Fig. 6. Cell survival measured by clonogenic assay for Hct116 cells
following PDT treatment with C16-TTP and TPYR-PP. After treatment
cells were grown for additional 9 days in culture medium. Cell survival was
expressed as a ratio of plating efficiency of treated cells to that of untreated
cells. Each experiments were performed tree times (mean ± SD).
8 G. Kramer-Marek et al. / Journal of Photochemistry and Photobiology B: Biology 84 (2006) 1–143.5. Clonogenic survival assay
MTS test was used to generally characterise the antipro-
liferative effect of the tested compounds following light
irradiation of cell cultures. This test does not allow to state
unequivocally if the observed proliferation inhibition is
reversible or not since it only gives information about the
behaviour of certain metabolic functions (mitochondrial
activity). The final result is additionally influenced by the
rate of cellular divisions and by the rate of cell death. This
is why, in order to confirm the results obtained using MTS
test, also clonogenic assays were performed using chosen
cell lines (Hct116 and Me45) and varying doses of light
energy.
The results in Figs. 6 and 7 were obtained by compari-
son with the colony survival of untreated cells (100%).
They are in agreement with MTS data. As can be seen,
light alone at doses 5–15 J/cm2 was non-toxic for either cell
line. The application of 1 lM of porphyrin derivatives
without irradiation slightly diminished the surviving
fractions (SF = 85–97%) of cells, indicating relatively low
dark toxicity. In both cell lines the photodynamic effectincreased with light energy applied. However, after expo-
sure of both cell lines to combined effect of sensitiser and
light, higher efficiency of TPYR-PP, compared to
110
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Fig. 7. Cell survival measured by clonogenic assay for Me45 cells
following PDT treatment with C16-TTP and TPYR-PP. After treatment
cells were grown for additional 9 days in culture medium. Cell survival was
expressed as a ratio of plating efficiency of treated cells to that of untreated
cells. Each experiments were performed tree times (mean ± SD).
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that human colon adenocarcinoma cells were more sensi-
tive to PDT treatment (especially with pyridyl-porphyrin
derivative, TPYR-PP), than malignant melanoma cells.
The surviving fraction of Hct116 cells after 15 J/cm2 dose
(Fig. 6) was two order of magnitude lower than that of
malignant melanoma Me45 cells (Fig. 7).
3.6. Intracellular localisation of C16-TTP and TPYR-PP in
Me45 cells
For PDT to be effective, the localisation of photosensi-
tiser inside the cell is of substantial importance. It deter-
mines the mechanisms set in motion in the wake of
photodynamic reactions. The manner according to which
sensitisers are taken up by cells is related to their chemical
nature and so is their localisation in intracellular microen-
vironment. This is why intracellular localisation of the
studied porphyrin derivatives was analysed using confocal
microscopy. The experiments were carried out using
human melanoma cells Me45 which appeared relatively
refractory to PDT therapy with the studied compounds.
The photosensitiser localisation was assessed after 4 and
12 h following conclusion of transfection. In both cases it
appeared similar. After 4 h accumulation was stronger in
the plasma membrane and in peripheral regions of the
cytoplasm (Fig. 8B). In no case fluorescence was nucleus-
localised. After 12 h condensation of both derivatives was
seen mainly in organelles around cell nucleus (Fig. 8C
and D). More precise determination of their localisation
requires further studies involving specific organelle mark-
ers. For comparative purposes also intracellular localisa-
tion of Photofrin II (5 lg/ml) was checked after 12 h
incubation. In this case intensive fluorescence diffused
throughout the cytoplasm was seen (Fig. 8E). Using image
analysis software fluorescence intensity was also deter-mined by computing mean optical density corresponding
to horizontal projections of the cells treated with com-
pounds and control. The results are shown in Table 4. As
expected, the fluorescence intensity of TPYR-PP in cells
was far greater than that of C16-TTP. The ratio of optical
density measured in cells treated with TPYR-PP (after sub-
tracting the background) to the optical density of cells
exposed to C16-TTP is 1.6. TPYR-PP turned out to be a
more effective PDT photosensitiser in studied cell lines.
3.7. Determination of apoptotic cells
Cell death is induced via two mechanisms: apoptosis or
necrosis. Apoptosis is characterised by changes in cellular
morphology, such as shrinkage, cell surface blebbing, chro-
matin condensation and DNA fragmentation. This type of
morphology is different from the well-known necrotic type,
characterised by swelling organelles, clumping of chroma-
tin, breakdown of plasma membrane and, finally, total cell
disintegration [32].
In our study PDT-treated and untreated controls were
stained with AO/EB in order to verify the modes of cell
death based on their morphological changes. The investiga-
tions were carried out on Hct116 cell line which showed to
be the most sensitive to PDT. Two energy doses were used:
7.5 and 15 J/cm2. Analysis was done right after irradiation
and after 3, 6, 12, and 24 h. One thousand cells were eval-
uated under fluorescent microscope (objective 40·), simul-
taneously using phase contrast. Percentage of undamaged
cells, those in apoptosis and necrosis and cells undergoing
mitosis were calculated.
Fig. 9A–D shows the results for C16-TTP derivative.
Treatment of Hct116 cells only with light doses 7.5 and
15 J/cm2 is almost non-toxic (90–95% live cells, and very
few apoptotic and necrotic cells). Differentiation of
Hct116 cell response treated with C16-TTP is clearly
dependent on energy dose used. Cells quickly undergo
apoptosis, which is expected after PDT. Even shortly after
irradiation (0–3 h, Fig. 9A–B) the percentage of apoptotic
cells was ca. 25–37% for both low and high energy dose.
For the higher dose after 3 h there were 14% of necrotic
cells. After longer time periods the percentage of necrotic
cells significantly increased for cultures treated with this
energy dose, reaching 70% after 24 h (Fig. 9D). In the case
of cells irradiated with 7.5 J/cm2 dose after 3 h there was
only a minor percentage of necrotic cells. At further time
points their number slowly raised reaching ca. 35% after
24 h (Fig. 9D). Apoptotic cells in this group show initial
rise, but the percentage decreases with time, resulting in
the microscopic picture being finally dominated by necrotic
cells.
The results obtained for TPYR-PP (Fig. 10A–D) mark-
edly differ from the results obtained for C16-TTP, although
here one can notice as well differentiation of cellular
response depending on light energy dose used. In this case,
however, cells treated with both lower and higher energy
doses exhibited a substantially lower percentage of
Fig. 8. Intracellular distribution of TPYR-PP, C16-TTP and PH in Me45 cells evaluated by confocal microscopy. 5-Chloromethylfluorescein diacetate
(CMFDA) was used as a marker molecule. Porphyrins were excited by argon ion laser at 488 nm (red fluorescence image, channel I) and CMFDA by neon
laser at 543 nm (green fluorescence image, channel II); combined multitruck system image (Ch I + Ch II) presents both type of fluorescence.
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Fig. 9. Distribution of Hct116 cells (live, mitotic, apoptotic or necrotic)
after PDT treatment with C16-TTP in function of light energy applied and
post-treatment time elapsed.
Table 4
Intensity of the fluorescence from intracellular accumulation of C16-TTP
and TPYR-PP
Group Cells Background
Optical density (d.u.a) Optical density (d.u.a)
Control 0.00 0.00
TPYR-PP 43.40 6.27
C16-TTP 24.95 2.03
Ten images were taken for each kind of lipoplex-entrapped porphyrins
and control cells. Every image features 5–7 cells. Mean densitometric value
was calculated after background fluorescence subtraction.
a d.u., density units.
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15% cells showed features typical of apoptotic death. Thus,
it seems that TPYR-PP use leads to necrosis as a dominant
mode of death. For higher energy dose, just after irradia-
tion, ca. 18% of cells were necrotic and the observed effect
markedly increased with time. After 12 h the necrotic cells
in the group irradiated with 15 J/cm2 dose reached 37%.
After 24 h in the group treated with the same dose there
was only 8% of live cells and more than 70% of cells were
necrotic (Fig. 10D).
4. Discussion
Novel compounds that exhibit better therapeutic effi-
cacy, lesser toxicity and which could be obtained at a lower
costs, compared to presently used sensitisers, have been for
many years the topic of extensive research. The effective-
ness of photodynamic therapy strongly depends upon pho-
tochemical properties of photosensitisers and, in particular,
upon the yield of singlet oxygen generation [33]. Both com-
pounds studied TPYR-PP and C16-TTP are characterised
by relatively high efficiency of singlet oxygen generation
that is comparable or higher than that shown by current
photosensitisers used in in vivo applications [34,35].
In view of the combined errors of the photophysical
experiments, there is no statistically significant difference
between the values obtained for the triplet and for the sin-
glet-oxygen quantum yields of C16-TPP and TPYR-PP
(see Table 2). The profile of the singlet oxygen decay curve
is consistent with a fast formation from the quenched trip-
let state of the porphyrin (sT(air)  300 ns). Triplet–triplet
energy transfer from the sensitiser to oxygen ground-state
occurs with unit efficiency upon collision, forming the O2
(1Dg):
Porph (T1)+
3O2! Porph (S0)+ 1O2
The rate of this reaction should approach the limit of one-
ninth of the diffusion-controlled constant [15]. Taking
[O2] = 1.81 · 103 M for toluene at room temperature,
Eq. (1) gives kq = 2 · 109 M1 s1 for both compounds,
which is very close to the theoretical limit of 1
9
kdiff ¼
3:4 109 M1 s1.
kq=(1/sair-1/sN2)/[O2] ð1ÞThe enhanced triplet quantum yield of TPYR-PP in tenta-
tively assigned to an increase in the intersystems crossing
rate of this sensitiser, and this can be originated by the
nature of the pyridyl group. Groups with electrons in
non-bonded orbitals tend to favour the conversion between
singlet and triplet states.
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novel porphyrin derivatives, C16-TTP and TPYR-PP. For
our study we chose three neoplastic cell lines showing var-
iable resistance to PDT treatment: Me45 human mela-
noma, B16(F10) murine melanoma and Hct116 humancolon adenocarcinoma. According to literature data, mela-
notic cells are thought to be particularly resistant to PDT,
contrarily to carcinoma [36].
In recent years a progressive increase in melanoma mor-
bidity throughout the world has been recorded among peo-
ple of Caucasian ancestry. Melanoma is a very invasive
kind of neoplasm with a tendency of rapid metastatic
spread. This is why there is a lot of scepticism concerning
PDT application for these tumours, all the more because
presence of melanin, absorbing in the 500 nm region,
may additionally hamper the effectiveness of PDT. Melanin
may act as a free radical scavenger although the extent of
such effect is limited [37]. In any case, it has to be remem-
bered that skin is one of the most accessible targets for
PDT which raises hope that this method some day might
compete with respect to more traditional treatments and
makes search for a photosensitiser effective against mela-
noma cells justified. Studies of ATX-S10(Na) have shown
that this chlorine-type photosensitiser at 50 lg/ml caused
99% death of melanoma cells irradiated with 10 J/cm2
[33]. Equally promising are the results of using indocyanin
green as a photosensitiser in treating SKMEL 188 human
melanoma cells and S91 murine melanoma cells [38]. These
results not only confirm the possibility of using PDT in
treating melanoma but corroborate the results presented
herein, i.e. that yield of singlet oxygen generation for both
examined photosensitisers was sufficient to inhibit prolifer-
ation of melanoma cells. The higher yield of singlet oxygen
production of the TPYR-PP compound might be in part
responsible for the higher efficiency demonstrated by this
compound, although higher concentration in cells con-
firmed by confocal microscopy is not without importance.
The use of cationic liposomes as a carrier of porphyrins
enabled their efficient transfer into cells. It has been known
that the mode of transfer strongly influences subsequent
localisation of photosensitiser in cells. Penetration of pho-
tosensitiser-containing liposomes into cells by endocytosis
strongly increases photodynamic efficiency of the PDT
agent [39]. In 2001, Damoiseau et al. [40] have observed
an 85% proliferation inhibition of WiDr cells’ following
administration of liposome incorporated bacteriochlorin
a and irradiation of cultures with 10 J/cm2. Only 40% inhi-
bition was seen when photosensitiser was merely added
alone to the medium. The observed improvement was
probably the result of lack of aggregation of photosensi-
tiser molecules administered in liposomal form. It is well
known that only monomeric forms of photosensitiser exhi-
bit high yield of singlet oxygen generation [41].
It is noteworthy that both porphyrin derivatives are
highly photostable. Neither one undergoes photodegrada-
tion following irradiation doses used to investigate the
PDT effect.
In order to assess photosensitising abilities of both C16-
TTP and TPYR-PP two methods were used: MTS test and
clonogenic test. They allow differentiating between some
aspects of cellular death. We conclude that neither com-
pound shows ‘‘dark’’ cytotoxicity, however, both are
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light irradiation. The progressive inhibition of proliferative
capabilities was proportional to irradiation dose and time
elapsed thereafter. It is difficult, however, to compare these
results with literature data due to different origin of cell
lines or the nature of photosensitisers.
Intracellular localisation study of C16-TTP and TPYR-
PP, performed using confocal microscopy, has shown that
fluorescence appears initially in regions adjacent to cyto-
plasmic membrane, later becoming more pronounced in
areas around nuclear membrane. These changes suggest
that this is the result of translocation of either derivative
towards nucleus and adjacent areas, involving mitochon-
dria and endoplasmatic reticulum. In case of Photofrin
II, after 4 h of incubation evenly distributed fluorescence
can be seen throughout the cytoplasm. Differences in
intracellular localisation between investigated compounds
and Photofrin II are due to different chemical properties
and a different translocation mechanism (diffusion vs.
endocytosis).
Our results show that the mechanism of action for the
studied compounds affects the coexisting processes of
apoptosis and necrosis. The presented data are based on
of morphological differentiation criteria between apoptotic
and necrotic cells, as established by Lelli et al. [20]. They
require confirmation by independent techniques such as
flow cytometry, immunocytochemistry as well as biochem-
ical studies. Nonetheless, analysis of the gathered data sug-
gests that the manner of cell death following application of
either one of the examined compounds depends on light
irradiation dose used. In either case, when high dose
(15 J/cm2) was used the dominating effect was necrosis.
Almost total inhibition of cellular proliferation was then
observed.
5. Conclusion
Both studied porphyrin derivatives TPYR-PP (5-(4-
hydroxyphenyl)-10,15,20-tritolylpor) and C16-TTP (5-(4-
hexadecyloxyphenyl)-10,15,20-tri-pyridylporphyrin) were
chemically well characterised. They are photodynamicly
active, effectively inducing cell death when light activated,
presumably due to the efficient generation of singlet oxy-
gen. Singlet oxygen is produced with unit efficiency upon
collision of the triplet of the compounds with ground-state
oxygen. The phototoxicity towards cancer cells showed
light-dose and cell line dependent characteristics. Such type
of porphyrin derivatives seem to be promising agents for
PDT treatment of neoplasms. Further quantitative data
about stability, concentration, and retention in cells need
to be gathered. In vivo use would probably require applica-
tion of more sophisticated (for example: targeted) carriers.
6. Abbreviations
AO acridine orange
BSA bovine serum albuminC16-TTP 5-(4-hydroxyphenyl)-10,15,20-tritolylporphyrin
DMF dimethylformamide
EB ethidium bromide
PDD photodynamic diagnostics
PDT photodynamic therapy
TLC thin-layer chromatography
TPYR-PP 5-(4-hexadecyloxyphenyl)-10,15,20-tri-pyr-
idylporphyrin
NA numerical aperture
RT room temperature
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